Safety and Efficacy Study of GSK2838232 in Human Immunodeficiency Virus (HIV)-1 Infected Adults
Clinical trial NCT03045861 · COMPLETED
Trial details
- NCT number
- NCT03045861
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-17
- Primary completion
- 2018-04-23
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.